Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Testing for hereditary breast and ovarian cancer in the southeastern United States.

Annals of surgery - 1 May 2000

Miron A, Schildkraut J M, Rimer B K, Winer E P, Sugg Skinner C, Futreal P A, Culler D, Calingaert B, Clark S, Kelly Marcom P, Iglehart J D

Abstract excerpt

OBJECTIVES: To detail characterization of mutations and uncharacterized variants in the breast cancer susceptibility genes BRCA1 and BRCA2, as observed in a population of breast cancer patients from the southeastern United States, and to examine baseline characteristics of women referred for counseling and testing and provide a preliminary look at how counseling and testing affected intentions toward prophylactic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Attitude to Health
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Counseling

Share to Decision Trees

Share to Genes, BRCA1

Share to Genetic Testing

Share to Ovarian Neoplasms

Share to Southeastern United States

Source

Open in PubMed Open full text

Identifiers

PMID: 10767783
DOI: 10.1097/00000658-200005000-00002
PMCID: PMC1421049

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Testing for hereditary breast and ovarian cancer in the southeastern United States.PMID 10767783Read ↗

Hereditary cancer risk notification and testing: how interested is the general population?Semantic proximity Read ↗

Recognizing BRCA gene mutation risk subsequent to breast cancer diagnosis in southwestern Ontario.Semantic proximity Read ↗

Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.Semantic proximity Read ↗

Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2.Semantic proximity Read ↗

Experiences from a pilot program bringing BRCA1/2 genetic screening to theUS Ashkenazi Jewish population.Semantic proximity Read ↗

Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening.Semantic proximity Read ↗

Factors associated with decisions about clinical BRCA1/2 testing.Semantic proximity Read ↗

Early use of clinical <i>BRCA1/2</i> testing: Associations with race and breast cancer riskSemantic proximity Read ↗

Clinicians' attitudes toward general screening of the Ashkenazi-Jewish population for prevalent founder BRCA1/2 and LRRK2 mutations.Semantic proximity Read ↗

Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.Semantic proximity Read ↗

To reflex or not: additional BRCA1/2 testing in Ashkenazi Jewish individuals without founder mutations.Semantic proximity Read ↗

Attitudes toward the genetic testing of children among adults in a Utah-based kindred tested for a BRCA1 mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.